Sophie Papa

4.3k total citations · 1 hit paper
57 papers, 1.8k citations indexed

About

Sophie Papa is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sophie Papa has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 13 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sophie Papa's work include CAR-T cell therapy research (21 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Immunotherapy and Immune Responses (8 papers). Sophie Papa is often cited by papers focused on CAR-T cell therapy research (21 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Immunotherapy and Immune Responses (8 papers). Sophie Papa collaborates with scholars based in United Kingdom, Switzerland and United States. Sophie Papa's co-authors include James Spicer, Mieke Van Hemelrijck, Andrew Cope, Charlotte Moss, Beth Russell, Aida Santaolalla, Gincy George, John Maher, May CI van Schalkwyk and Katherine Sharrocks and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sophie Papa

56 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

2024 62 citations Adam J. Schoenfeld, Sylvia M. Lee et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie Papa United Kingdom	23	952	360	287	281	271	57	1.8k
Faiz Anwer United States	23	1.1k 1.2×	458 1.3×	164 0.6×	782 2.8×	102 0.4×	328	2.5k
Qingzhu Jia China	21	971 1.0×	627 1.7×	551 1.9×	628 2.2×	658 2.4×	55	2.4k
Mark U. Rarick United States	23	1.3k 1.3×	206 0.6×	194 0.7×	356 1.3×	254 0.9×	48	2.7k
Guglielmo Nasti Italy	32	1.7k 1.8×	198 0.6×	427 1.5×	386 1.4×	376 1.4×	154	3.1k
Michael Rytting United States	31	1.3k 1.4×	312 0.9×	164 0.6×	1.1k 4.0×	119 0.4×	96	4.2k
Ronald Sobecks United States	29	1.2k 1.2×	592 1.6×	237 0.8×	669 2.4×	125 0.5×	255	3.5k
Ibrahim Aldoss United States	29	899 0.9×	251 0.7×	95 0.3×	550 2.0×	122 0.5×	190	2.5k
Hyoung Jin Kang South Korea	27	673 0.7×	394 1.1×	399 1.4×	600 2.1×	180 0.7×	248	2.9k
Valentino Conter Italy	36	760 0.8×	204 0.6×	225 0.8×	608 2.2×	176 0.6×	154	4.0k
David M. Mintzer United States	22	545 0.6×	402 1.1×	477 1.7×	439 1.6×	372 1.4×	60	2.3k

Countries citing papers authored by Sophie Papa

Since Specialization

Citations

This map shows the geographic impact of Sophie Papa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Papa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Papa more than expected).

Fields of papers citing papers by Sophie Papa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Papa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Papa. The network helps show where Sophie Papa may publish in the future.

Co-authorship network of co-authors of Sophie Papa

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Papa. A scholar is included among the top collaborators of Sophie Papa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Papa. Sophie Papa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willsmore, Zena, Lucy H. Booth, Akshay J. Patel, et al.. (2025). Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma. Journal for ImmunoTherapy of Cancer. 13(5). e011682–e011682. 2 indexed citations

Schoenfeld, Adam J., Sylvia M. Lee, Scott Gettinger, et al.. (2024). Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer Discovery. 14(8). 1389–1402. 62 indexed citations breakdown →

Boeke, Jef D., Kathleen H. Burns, Katherine B. Chiappinelli, et al.. (2023). Proceedings of the inaugural Dark Genome Symposium: November 2022. Mobile DNA. 14(1). 3 indexed citations

Maghsoudlou, Panagiotis, David D’Cruz, Mark Harries, et al.. (2023). The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports. Autoimmunity Reviews. 22(3). 103269–103269. 3 indexed citations

Berry, Philip, Yoh Zen, Sophie Papa, et al.. (2022). Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort. Liver International. 43(1). 147–154. 27 indexed citations

Alexander, James L., Hajir Ibraheim, Benjamin Shum, et al.. (2022). Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. Journal for ImmunoTherapy of Cancer. 10(9). e005490–e005490. 6 indexed citations

Márquez‐Rodas, Iván, Luigi Formisano, Sophie Papa, et al.. (2022). Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis. JMIR Cancer. 8(2). e35930–e35930. 5 indexed citations

Cheung, Anthony, Alicia M. Chenoweth, Jelmar Quist, et al.. (2022). CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models. Cancers. 14(14). 3361–3361. 11 indexed citations

Patel, Akshay J., Zena Willsmore, Naeem Khan, et al.. (2022). Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nature Communications. 13(1). 3148–3148. 41 indexed citations

10.

Sagkriotis, Alexandros, Iván Márquez‐Rodas, Luigi Formisano, et al.. (2022). POSA357 Social Media Listening for Melanoma Care Across European Markets. Value in Health. 25(1). S219–S219. 1 indexed citations

11.

Crescioli, Silvia, et al.. (2021). Utilizing Immunocytokines for Cancer Therapy. Antibodies. 10(1). 10–10. 32 indexed citations

12.

Schalkwyk, May CI van, Sjoukje J. C. van der Stegen, Leticia Bosshard‐Carter, et al.. (2021). Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells. Cells. 10(7). 1797–1797. 6 indexed citations

13.

Moss, Charlotte, Saoirse Dolly, Beth Russell, et al.. (2020). One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer. Cancer Control. 27(3). 1148386108–1148386108. 5 indexed citations

14.

Pellizzari, Giulia, Silvia Crescioli, Silvia Mele, et al.. (2019). IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states. EBioMedicine. 43. 67–81. 49 indexed citations

15.

Ibraheim, Hajir, Michael Green, Sophie Papa, & Nick Powell. (2019). Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis. BMJ Case Reports. 12(4). e226481–e226481. 9 indexed citations

16.

Lang-Lazdunski, Loı̈c, Andrea Billè, Sophie Papa, et al.. (2014). Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience. Journal of Thoracic and Cardiovascular Surgery. 149(2). 558–566. 56 indexed citations

17.

Sharrocks, Katherine, James Spicer, D. Ross Camidge, & Sophie Papa. (2014). The impact of socioeconomic status on access to cancer clinical trials. British Journal of Cancer. 111(9). 1684–1687. 110 indexed citations

18.

Schalkwyk, May CI van, Sophie Papa, Jean‐Pierre Jeannon, et al.. (2013). Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer. PubMed. 24(3). 134–142. 105 indexed citations

19.

Papa, Sophie, Sanjay Popat, Riyaz Shah, et al.. (2013). Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy. Journal of Thoracic Oncology. 8(6). 783–787. 62 indexed citations

20.

Schalkwyk, May CI van, Sophie Papa, Jean‐Pierre Jeannon, et al.. (2013). Design of a Phase I Clinical Trial to evaluate intra-tumoral delivery of ErbB-targeted CAR T-cells in locally advanced or recurrent Head and Neck Cancer. 776275620–776275620. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact